Related references
Note: Only part of the references are listed.Y-box-binding protein 1 (YB1) in breast carcinomas: Relation to aggressive tumor phenotype and identification of patients at high risk for relapse
E. Mylona et al.
EJSO (2014)
Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence
Fernando Ortiz-Martinez et al.
HUMAN PATHOLOGY (2014)
PELP1 oncogenic functions involve alternative splicing via PRIVIT6
Monica Mann et al.
MOLECULAR ONCOLOGY (2014)
BRCA1 exon 11 a model of long exon splicing regulation
Michela Raponi et al.
RNA BIOLOGY (2014)
Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exons
Andrew Best et al.
NATURE COMMUNICATIONS (2014)
The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
Stephanie Cunha et al.
CELL REPORTS (2014)
Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties
X. He et al.
ONCOGENESIS (2014)
hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene
Hyun Kyung Oh et al.
APOPTOSIS (2013)
PRMT6 overexpression upregulates TSP-1 and downregulates MMPs: Its implication in motility and invasion
Nam Hyun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation
Ariel Shimoni-Sebag et al.
CARCINOGENESIS (2013)
The role of BRCA1 in DNA double-strand repair: Past and present
Kevin W. Caestecker et al.
EXPERIMENTAL CELL RESEARCH (2013)
The function of the RNA-binding protein hnRNP in cancer metastasis
Na Han et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2013)
RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues
Julian P. Venables et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Y-box Binding Protein-1 Contributes to Both HER2/ErbB2 Expression and Lapatinib Sensitivity in Human Gastric Cancer Cells
Tomohiro Shibata et al.
MOLECULAR CANCER THERAPEUTICS (2013)
HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition
Serena Bonomi et al.
NUCLEIC ACIDS RESEARCH (2013)
Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion
Yuying Liu et al.
NUCLEIC ACIDS RESEARCH (2013)
The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis
C. Zhou et al.
ONCOGENE (2013)
Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence
Y. Tang et al.
ONCOGENE (2013)
Estrogen Alters the Splicing of Type 1 Corticotropin-Releasing Hormone Receptor in Breast Cancer Cells
Suchita Lal et al.
SCIENCE SIGNALING (2013)
The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis
P. Yang et al.
SCIENTIFIC REPORTS (2013)
S6K1 Alternative Splicing Modulates Its Oncogenic Activity and Regulates mTORC1
Vered Ben-Hur et al.
CELL REPORTS (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer
Claudia Tammaro et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Versatility of RNA-Binding Proteins in Cancer
Laurence Wurth
COMPARATIVE AND FUNCTIONAL GENOMICS (2012)
Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes
Dennis H. Dowhan et al.
ENDOCRINE-RELATED CANCER (2012)
SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance
Rong Jia et al.
International Journal of Biological Sciences (2012)
c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis
Lucia Knopfova et al.
MOLECULAR CANCER (2012)
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
Olga Anczukow et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6
Sameer Phalke et al.
NUCLEIC ACIDS RESEARCH (2012)
Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells
Hannah L. Gautrey et al.
PLOS ONE (2012)
Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC
Shipra Das et al.
CELL REPORTS (2012)
The RNA-binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes
Minna-Liisa Aenkoe et al.
GENOME BIOLOGY (2012)
Identification and Regulation of c-Myb Target Genes in MCF-7 Cells
Anita M. Quintana et al.
BMC CANCER (2011)
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
Eleonor Olsson et al.
BMC CANCER (2011)
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Elianna M. Amin et al.
CANCER CELL (2011)
Splicing Factor hnRNP A2/B1 Regulates Tumor Suppressor Gene Splicing and Is an Oncogenic Driver in Glioblastoma
Regina Golan-Gerstl et al.
CANCER RESEARCH (2011)
RNA structure and the mechanisms of alternative splicing
C. Joel McManus et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Shuttling SR proteins: more than splicing factors
Laure Twyffels et al.
FEBS JOURNAL (2011)
The RNA polymerase II C-terminal domain promotes splicing activation through recruitment of a U2AF65-Prp19 complex
Charles J. David et al.
GENES & DEVELOPMENT (2011)
YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification
A. H. Davies et al.
ONCOGENE (2011)
iCLIP - Transcriptome-wide Mapping of Protein-RNA Interactions with Individual Nucleotide Resolution
Julian Konig et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Alternative Splicing of the Cyclin D1 Proto-Oncogene Is Regulated by the RNA-Binding Protein Sam68
Maria Paola Paronetto et al.
CANCER RESEARCH (2010)
Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Oncogene
Nicholas A. Olshavsky et al.
CANCER RESEARCH (2010)
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Charles J. David et al.
GENES & DEVELOPMENT (2010)
Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53
Renyuan Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene
Cristina Valacca et al.
JOURNAL OF CELL BIOLOGY (2010)
Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells
Libing Song et al.
JOURNAL OF PATHOLOGY (2010)
Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
Anna Lapuk et al.
MOLECULAR CANCER RESEARCH (2010)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David et al.
NATURE (2010)
iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution
Julian Koenig et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer
Aaron R. Thorner et al.
PLOS ONE (2010)
Alternative splicing and breast cancer
Martin Dutertre et al.
RNA BIOLOGY (2010)
Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles
Arindam Chaudhury et al.
RNA (2010)
MYB suppresses differentiation and apoptosis of human breast cancer cells
Yvette Drabsch et al.
BREAST CANCER RESEARCH (2010)
Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition
Valentina Evdokimova et al.
CANCER CELL (2009)
Breast Cancer Amplified Sequence 2, a Novel Negative Regulator of the p53 Tumor Suppressor
Ping-Chang Kuo et al.
CANCER RESEARCH (2009)
S6 Kinase 1 Regulates Estrogen Receptor α in Control of Breast Cancer Cell Proliferation
Rachel L. Yamnik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX
Shaohua Li et al.
JOURNAL OF PATHOLOGY (2009)
Cyclin D1b Variant Promotes Cell Invasiveness Independent of Binding to CDK4 in Human Bladder Cancer Cells
Chul Jang Kim et al.
MOLECULAR CARCINOGENESIS (2009)
Histone-Acetylated Control of Fibroblast Growth Factor Receptor 2 Intron 2 Polymorphisms and Isoform Splicing in Breast Cancer
Xuegong Zhu et al.
MOLECULAR ENDOCRINOLOGY (2009)
A missense mutation in the APC tumor suppressor gene disrupts an ASF/SF2 splicing enhancer motif and causes pathogenic skipping of exon 14
Vania Goncalves et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Mo Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Cancer-associated regulation of alternative splicing
Julian P. Venables et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells
Gene W. Yeo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Expression of HER2 and estrogen receptor α depends upon nuclear localization of Y-box binding protein-1 in human breast cancers
Teruhiko Fujii et al.
CANCER RESEARCH (2008)
Multiple alternative splicing markers for ovarian cancer
Roscoe Klinck et al.
CANCER RESEARCH (2008)
Identification of Alternative Splicing Markers for Breast Cancer
Julian P. Venables et al.
CANCER RESEARCH (2008)
Alternative Splicing and Tumor Progression
Claudia Ghigna et al.
CURRENT GENOMICS (2008)
The emerging role of splicing factors in cancer
Ana Rita Grosso et al.
EMBO REPORTS (2008)
Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2
Chaolin Zhang et al.
GENES & DEVELOPMENT (2008)
Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition
Jose M. Izquierdo
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling
Oak D. Jo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Alternative RNA splicing produces multiple forms of c-myb with unique transcriptional activities
John P. O'Rourke et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
HnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 Exon IIIc
David M. Mauger et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Multiple and specific mRNA processing targets for the major human hnRNP proteins
Julian P. Venables et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling
Alpana Soni et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5
Kazuo Fushimi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Caffeine regulates alternative splicing in a subset of cancer-associated genes: A role for SC35
Jia Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer
Chiun-Sheng Huang et al.
CLINICA CHIMICA ACTA (2007)
Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis
Ran Xiao et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
David J. Hunter et al.
NATURE GENETICS (2007)
U2AF-homology motif interactions are required for alternative splicing regulation by SPF45
Lorenzo Corsini et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis
Raul Catena et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Expression of RBM5-related factors in primary breast tissue
Nina D. Rintala-Maki et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Rotem Karni et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x
Maria Paola Paronetto et al.
JOURNAL OF CELL BIOLOGY (2007)
Differential signal transduction of alternatively spliced FGFR2 variants expressed epithelial in human mammary cells
Allison B. Moffa et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing
Donghang Cheng et al.
MOLECULAR CELL (2007)
Coregulators: transducing signal from transcription to alternative splicing
Didier Auboeuf et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
The connection between splicing and cancer
Anabella Srebrow et al.
JOURNAL OF CELL SCIENCE (2006)
Splicing factor Tra2-β1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene
Dirk O. Watermann et al.
CANCER RESEARCH (2006)
Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice
AP Baraniak et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion
CH Cheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene
C Ghigna et al.
MOLECULAR CELL (2005)
The Pso4 mRNA splicing and DNA repair complex interacts with WRN for processing of DNA interstrand cross-links
NX Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition
JM Izquierdo et al.
MOLECULAR CELL (2005)
Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability
XL Li et al.
CELL (2005)
Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation
YW He et al.
JOURNAL OF CELL SCIENCE (2005)
YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification
S Bergmann et al.
CANCER RESEARCH (2005)
Potentiation of estrogen receptor transcriptional activity by breast cancer amplified sequence 2
C Qi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-Related proteins CAPERα and CAPERβ
DH Dowhan et al.
MOLECULAR CELL (2005)
Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma
C Denkert et al.
CLINICAL CANCER RESEARCH (2004)
Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20
XL He et al.
CLINICAL CANCER RESEARCH (2004)
Splice variants as cancer biomarkers
BMN Brinkman
CLINICAL BIOCHEMISTRY (2004)
Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis
ST Shi et al.
JOURNAL OF VIROLOGY (2003)
Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb
A Kumar et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization
GC Scheper et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Emerging roles of BRCA1 alternative splicing
TI Orban et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2003)
SR protein expression and CD44 splicing pattern in human breast tumours
MT Pind et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells
J Sampath et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Role of P-glycoprotein in pharmacokinetics - Clinical implications
JH Lin et al.
CLINICAL PHARMACOKINETICS (2003)
Mouse DAM1 regulates pro-apoptotic activity of BLK in mammary epithelial cells
S Lee et al.
CANCER LETTERS (2002)
Signal-dependent regulation of splicing via phosphorylation of Sam68
N Matter et al.
NATURE (2002)
Amplification of the BCAS2 gene at chromosome 1p13.3-21 in human primary breast cancer
N Maass et al.
CANCER LETTERS (2002)
Targeted disruption of one allele of the Y-box protein gene, Chk-YB-1b, in DT40 cells results in major defects in cell cycle
SK Swamynathan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Listening to silence and understanding nonsense: Exonic mutations that affect splicing
L Cartegni et al.
NATURE REVIEWS GENETICS (2002)
Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1
M Janz et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
A negative coregulator for the human ER
JD Norris et al.
MOLECULAR ENDOCRINOLOGY (2002)
Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer
J Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function
M Mandal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion
J Côté et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b
A Schnelzer et al.
ONCOGENE (2000)
Spatio-temporal expression of the trans-acting splicing factors SF2/ASF and heterogeneous ribonuclear proteins A1/A1B in the myometrium of the pregnant human uterus:: A molecular mechanism for regulating regional protein isoform expression in vivo
AJ Pollard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)